Vyloy With Chemotherapy Approved for Gastric or Gastroesophageal Junction Adenocarcinoma

The FDA has approved zolbetuximab for the first-line treatment of adults with advanced gastric or gastroesophageal ...

NOVEMBER 4, 2024